The U.S. FDA announced on Thursday (May 5) that it was strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to the risk of a potentially life-threatening side effect.
The agency said it has now limited the use of the vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate.
FDA limits use of J&J vaccine due to blood clotting concerns. What happened to "safe" and "effective?"
— George Gammon (@GeorgeGammon) May 5, 2022
Great example why censorship of dissenting views is so dangerous. Raising any question about vaccine safety would've been labeled "disinformation," now it's proven factual. pic.twitter.com/lTp4WnPyPR
The FDA said its analysis had determined that the risk of thrombosis with thrombocytopenia syndrome after the administration of the injection warrants limiting of the authorization.
BREAKING! The day after a JAMA paper publishes significant signal evidence of increased risk for J&J post-vaccine Guillain-Barré Syndrome adverse reaction the FDA takes it away for people under 18. https://t.co/oORLOEHts7
— Justin Hart (@justin_hart) May 5, 2022
More vaccine updates here!https://t.co/I7y3psMeYT
Johnson & Johnson did not immediately respond to a Reuters request for comment.
FDA finally admits that the vaxx is not universally safe and good for everyone. https://t.co/Tl9aw70RU0
— Aaron Ginn (@aginnt) May 5, 2022